Extended report
Increased serum concentrations of soluble HLA-class I antigens in
hepatitis C virus related mixed cryoglobulinaemia
Sergio Migliaresia, Alessandro Bresciania b, Lucia Ambrosonea, Marcantonio Speraa b, Deborah Barbarulob, Vincenza Lombarib, Giuseppe Pirozzib, Guglielmo Borgiac, Maria Luisa Lombardib, Giuseppe Tirria, Ciro Manzob
a Istituto
di Clinica Medica, Reumatologia, Seconda Università degli Studi,
Napoli, Italy, b Servizio di Oncologia Sperimentale C,
Immunologia, Istituto Tumori Fondazione Pascale, Napoli, Italy, c Istituto di Malattie Infettive, Università
degli Studi "Federico II", Napoli, Italy
Correspondence to: Dr S Migliaresi, Istituto di Clinica Medica, Reumatologia, Seconda Università, Policlinico via Pansini 5, 80131 Napoli, Italy
Accepted for publication 13 August 1999
OBJECTIVE
To
investigate whether quantitative alterations of both
2microglobulin (
2µ) associated HLA
class I heavy chains (sHLA-I) and
2 µ free class I
heavy chains (sHLA-FHC) in sera of patients with hepatitis C virus
(HCV) infection occur and whether they distinguish patients with mixed
cryoglobulinaemia (MC).
METHODS
83 HCV
infected patients were studied and divided into three groups: (A)
without cryoglobulinaemia (n=21), (B) with polyclonal MC (n=20), (C)
with monoclonal MC (n=42). Serum sHLA-I and sHLA-FHC were measured by
double determinant radioimmunoassay using monoclonal antibodies:
TP25.99 as catching antibody, and NAMB-1 and HC-10 as revealing
antibodies. Western blot identified HLA-I isoforms.
RESULTS
The serum
concentrations of sHLA-I and of sHLA-FHC in HCV infected patients
versus controls were respectively 1.3(0.5) µg/ml (mean (SD)) versus
0.8 (0.3) (p<0.001) and 13.9 (7.1) ng/ml versus 9.2 (5) (p<0.001).
sHLA-I were 1.01 (0.4) µg/ml in group A, 1.04 (0.4) µg/ml in group
B, and 1.47 (0.4) µg/ml in group C (p=0.001). Statistical analysis
showed a significant difference versus controls for groups B (p<0.02)
and C (p<0.001). sHLA-FHC were 12.8 (8.3) ng/ml in group A, 17.2 (7.1)
ng/ml in group B, and 12.9 (6.2) ng/ml in group C (p<0.02). A
significant difference versus controls for each group was found
(p<0.02, p<0.001, and p<0.02, respectively). Different patterns of
sHLA-I isoforms were observed.
CONCLUSIONS
Increased
serum concentrations of sHLA-I and sHLA-FHC characterise HCV infected
patients. The highest sHLA-I concentrations seem to distinguish
patients with monoclonal MC. In this last condition sHLA could play a
part in the HCV escape and in B cell proliferation. The significance of
sHLA-FHC is still undefined.
© 2000 by Annals of the Rheumatic Diseases
This article has been cited by other articles:
-
Toussirot, E, Saas, P, Pariset, J, Chabod, J, Tiberghien, P, Wendling, D
(2006). Decreased levels of serum soluble HLA class I antigens in HLA-B27 positive spondyloarthropathies. Ann Rheum Dis
65: 279-280
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
